Loading company…
Meishangjie Biotechnology develops recombinant collagen skincare products and medical devices.
Founded in 2021, Meishangjie Biotechnology develops bio-active collagen products, including skincare products and Class II medical devices for dermatology, ophthalmology and surgical applications. The company is based in Suzhou, China. It closed a Series A round in July 2024 and raised undisclosed Series A+ funding in October 2025 from Sumin Investment and Originvest Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in